Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk

• Richard D Neal,
• Kevin Franks,
• David Torgerson,
• Michael Darby,
• Una MacLeod,
• Mark Sculpher,
• Philip AJ Crosbie,
• Irene Simmonds,
• Martyn Kennedy,
• Nazia Ahmed,
• Ann Cochrane,
• Mike Messenger,
• Puvanendran Tharmanathan

Affiliations

Richard D Neal

School of Medicine, University of Leeds, Leeds, UK

Kevin Franks

2 St James’ University Hospital, Leeds, UK

David Torgerson

professor

Michael Darby

Department of Radiology, North Bristol NHS Trust, Bristol, UK

Una MacLeod

Lancaster University, Oncology Institute of Southern Switzerland, Hull York Medical School

Mark Sculpher

Centre for Health Economics, University of York, York, UK

Philip AJ Crosbie

Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, UK

Irene Simmonds

Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

Martyn Kennedy

Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Nazia Ahmed

Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

Ann Cochrane

York Trials Unit, Department of Health Sciences, University of York, York, UK

Mike Messenger

Leeds Centre for Personalised Medicine and Health, University of Leeds, Leeds, UK

Puvanendran Tharmanathan

York Trials Unit, Department of Health Sciences, University of York, York, UK